3 month supply of tirzepatide Compounded GLP-1/GIP (3 Month) – Verge 1 and GIP therapy Tirzepatide Rapid Disintegrating Tablets (Sublingual)

The establishment is not registered with FDA as required by Section 510 of the FFDCA and has not listed the device as required by Section 510(j) of the FFDCA or obtained applicable premarket notification clearance as required by Section 510(k) of the FFDCA

Solvent base: water for injection (CAS: 7732-18-5

Vague claims that don't withstand mechanistic scrutiny

[PMC free article] [PubMed] [Google Scholar] 84.Yin J., Ren W., Yang G., Duan J., Huang X., Fang R., Li C., Li T., Yin Y., Hou Y., et al

To lessen after effects from injection, gently massage the muscle at the injection site for 2-3 minutes and use the muscle for several minutes afterward

You would redesign your prescribing workflow around documented clinical necessity